Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Blood marker may flag Alzheimer's-related changes in Down syndrome decades before symptoms appear

Decades before the first symptoms of Alzheimer's disease appear, some changes associated with the disease may begin to leave a trace in the blood. A study by the Sant Pau Research Institute (IR Sant Pau) has found that, in people with Down syndrome, levels of β-synuclein, a protein related to synaptic function, begin to rise in the third decade of life, long before symptoms appear and earlier…

Blood marker may flag Alzheimer's-related changes in Down syndrome decades before symptoms appear

A recent study conducted by the Sant Pau Research Institute in Barcelona has unveiled a potential blood marker that could flag Alzheimer's-related changes in individuals with Down syndrome decades before symptoms manifest. The research, published in Alzheimer's & Dementia, reveals that levels of β-synuclein, a protein linked to synaptic function, begin to rise in the third decade of life in those with Down syndrome, even before any symptoms of the disease appear.

This finding positions β-synuclein as a promising early indicator of synaptic alterations associated with Alzheimer's. With an exceptionally high risk of developing Alzheimer's, people with Down syndrome face a median age of diagnosis for prodromal Alzheimer's of around 50 years, while dementia is typically diagnosed at around 54 years.

The study's lead author, Dr. Olivia Belbin, emphasizes that understanding these earliest changes is crucial for identifying when synapses begin to fail and for studying potential interventions at earlier stages of the disease. While other blood biomarkers such as pTau217, NfL, and GFAP reflect different Alzheimer's-related processes, β-synuclein provides insight into synaptic dysfunction and degeneration.

Rewritten by urgent.news; may contain errors — check the original.

Read the original at medicalxpress.com →

Report a problem with this story

More in Health & Medicine

More from Wednesday 7 October →